Metformin Modifies Plasma Microbial-derived Extracellular Vesicles in Polycystic Ovary Syndrome with Insulin Resistance

Overview

Journal J Ovarian Res

Publisher Biomed Central

Specialties Gynecology & Obstetrics
Reproductive Medicine

Date 2024 Jul 3

PMID 38956672

Authors

Liping Hu

Guolin Hong

Jingzhi Li

Mengkun Chen

Chih-Jung Chang

Po-Jen Cheng

Zhimei Zhang

Xinli Zhang

Huiping Chen

Yingting Zhuang

Yuqin Li

Affiliations

Soon will be listed here.

Abstract

Introduction: This study investigated changes in plasma microbial-derived extracellular vesicles (EVs) in patients with polycystic ovary syndrome and insulin resistance (PCOS-IR) before and after metformin treatment, and aimed to identify bacterial taxa within EVs that were biologically and statistically significant for diagnosis and treatment.

Methods: The case-control study was conducted at Xiamen Chang Gung Hospital, Hua Qiao University. Plasma samples were collected from five PCOS-IR patients of childbearing age before and after 3 months of metformin treatment, and the samples were sequenced. The diversity and taxonomic composition of different microbial communities were analyzed through full-length 16 S glycosomal RNA gene sequencing.

Results: After metformin treatment, fasting plasma glucose levels and IR degree of PCOS-IR patients were significantly improved. The 16 S analysis of plasma EVs from metformin-treated patients showed higher microbial diversity. There were significant differences in EVs derived from some environmental bacteria before and after metformin treatment. Notably, Streptococcus salivarius was more abundant in the metformin-treated group, suggesting it may be a potential probiotic.

Discussion: The study demonstrated changes in the microbial composition of plasma EVs before and after metformin treatment. The findings may offer new insights into the pathogenesis of PCOS-IR and provide new avenues for research.

Citing Articles

Correction: Metformin modifies plasma microbial-derived extracellular vesicles in polycystic ovary syndrome with insulin resistance.

Hu L, Hong G, Li J, Chen M, Chang C, Cheng P J Ovarian Res. 2024; 17(1):155.

PMID: 39068436 PMC: 11282826. DOI: 10.1186/s13048-024-01481-6.

References

Rosenfield R, Ehrmann D . The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev. 2016; 37(5):467-520. PMC: 5045492. DOI: 10.1210/er.2015-1104. View

Wu H, Esteve E, Tremaroli V, Khan M, Caesar R, Manneras-Holm L . Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med. 2017; 23(7):850-858. DOI: 10.1038/nm.4345. View

Wang L, Zhou J, Gober H, Leung W, Huang Z, Pan X . Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype. Biomed Pharmacother. 2020; 133:110958. DOI: 10.1016/j.biopha.2020.110958. View

Pedersen H, Gudmundsdottir V, Nielsen H, Hyotylainen T, Nielsen T, Jensen B . Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016; 535(7612):376-81. DOI: 10.1038/nature18646. View

Sanna S, van Zuydam N, Mahajan A, Kurilshikov A, Vich Vila A, Vosa U . Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet. 2019; 51(4):600-605. PMC: 6441384. DOI: 10.1038/s41588-019-0350-x. View

Sun L, Xie C, Wang G, Wu Y, Wu Q, Wang X . Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat Med. 2018; 24(12):1919-1929. PMC: 6479226. DOI: 10.1038/s41591-018-0222-4. View

Zeng B, Lai Z, Sun L, Zhang Z, Yang J, Li Z . Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study. Res Microbiol. 2018; 170(1):43-52. DOI: 10.1016/j.resmic.2018.09.002. View

Zhao X, Jiang Y, Xi H, Chen L, Feng X . Exploration of the Relationship Between Gut Microbiota and Polycystic Ovary Syndrome (PCOS): a Review. Geburtshilfe Frauenheilkd. 2020; 80(2):161-171. PMC: 7035130. DOI: 10.1055/a-1081-2036. View

He F, Li Y . Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review. J Ovarian Res. 2020; 13(1):73. PMC: 7301991. DOI: 10.1186/s13048-020-00670-3. View

10.

Abu Hashim H . Twenty years of ovulation induction with metformin for PCOS; what is the best available evidence?. Reprod Biomed Online. 2015; 32(1):44-53. DOI: 10.1016/j.rbmo.2015.09.015. View

11.

Bordewijk E, Nahuis M, Costello M, van der Veen F, Tso L, Mol B . Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev. 2017; 1:CD009090. PMC: 6464837. DOI: 10.1002/14651858.CD009090.pub2. View

12.

Robbins P, Morelli A . Regulation of immune responses by extracellular vesicles. Nat Rev Immunol. 2014; 14(3):195-208. PMC: 4350779. DOI: 10.1038/nri3622. View

13.

Cabreiro F, Au C, Leung K, Vergara-Irigaray N, Cocheme H, Noori T . Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell. 2013; 153(1):228-39. PMC: 3898468. DOI: 10.1016/j.cell.2013.02.035. View

14.

Xue J, Li X, Liu P, Li K, Sha L, Yang X . Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice. Endocr J. 2019; 66(10):859-870. DOI: 10.1507/endocrj.EJ18-0567. View

15.

Rodriguez J, Hiel S, Delzenne N . Metformin: old friend, new ways of action-implication of the gut microbiome?. Curr Opin Clin Nutr Metab Care. 2018; 21(4):294-301. DOI: 10.1097/MCO.0000000000000468. View

16.

Zhang W, Xu J, Yu T, Chen Q . Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice. Biomed Pharmacother. 2019; 118:109131. DOI: 10.1016/j.biopha.2019.109131. View

17.

Khalyfa A, Castro-Grattoni A, Gozal D . Cardiovascular morbidities of obstructive sleep apnea and the role of circulating extracellular vesicles. Ther Adv Respir Dis. 2019; 13:1753466619895229. PMC: 6923690. DOI: 10.1177/1753466619895229. View

18.

Jiang X, Li J, Zhang B, Hu J, Ma J, Cui L . Differential expression profile of plasma exosomal microRNAs in women with polycystic ovary syndrome. Fertil Steril. 2020; 115(3):782-792. DOI: 10.1016/j.fertnstert.2020.08.019. View

19.

Che X, Jian F, Chen C, Liu C, Liu G, Feng W . PCOS serum-derived exosomal miR-27a-5p stimulates endometrial cancer cells migration and invasion. J Mol Endocrinol. 2019; 64(1):1-12. DOI: 10.1530/JME-19-0159. View

20.

Yuan D, Luo J, Sun Y, Hao L, Zheng J, Yang Z . PCOS follicular fluid derived exosomal miR-424-5p induces granulosa cells senescence by targeting CDCA4 expression. Cell Signal. 2021; 85:110030. DOI: 10.1016/j.cellsig.2021.110030. View